BML210
-
Catalog numberB1128-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_nameN-(2-aminophenyl)-N'-phenyl-octanediamide; CAY10433
-
DescriptionBML-210 (also known as CAY10433), is a histone deacetylase (HDAC) inhibitor. BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells.
-
CAS Number537034-17-6
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₀H₂₅N₃O₂
-
Molecular Weight339.43
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>20 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA histone deacetylase (HDAC) inhibitor.
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD02062139
-
PubChem CID9543540
-
SMILESC1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NC2=CC=CC=C2N
-
InChiInChI=1S/C20H25N3O2/c21-17-12-8-9-13-18(17)23-20(25)15-7-2-1-6-14-19(24)22-16-10-4-3-5-11-16/h3-5,8-13H,1-2,6-7,14-15,21H2,(H,22,24)(H,23,25)
-
InChi KeyRFLHBLWLFUFFDZ-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameBML210
-
Alternative nameBML210
-